Literatur
- 1
Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Arias L H.
Under-reporting
of adverse drug reactions. Estimate based on a spontaneous reporting scheme and
a sentinel system.
Eur J Clin
Pharmacol.
1998;
54
483-488
- 2
Azaz-Livshits T, Levy M, Sadan B, Shalit M, Geisslinger G, Brune K.
Computerized
surveillance of adverse drug reactions in hospital: pilot study.
Br J
Clin
Pharmacol.
1998;
45
309-314
- 3
Bates D W, Cullen D J, Laird N, Petersen L A, Small S D, Servi D, Laffel G, Sweitzer B J,
Shea B F, Hallisey R. et
al .
Incidence of adverse drug events and potential adverse drug
events. Implications for prevention. ADE Prevention Study
Group.
JAMA.
1995;
274
29-34
- 4
Bates D W, Spell N, Cullen D J, Burdick E, Laird N, Petersen L A, Small S D, Sweitzer B J,
Leape L L.
The
costs of adverse drug events in hospitalized patients. Adverse Drug Events
Prevention Study
Group.
JAMA.
1997;
277
307-311
- 5
Brennan T A, Leape L L, Laird N M, Hebert L, Localio A R, Lawthers A G, Newhouse J P,
Weiler P C, Hiatt H H.
Incidence
of adverse events and negligence in hospitalized patients. Results of the
Harvard Medical Practice Study I.
N Engl J
Med.
1991;
324
370-376
- 6
Classen D C, Pestotnik S L, Evans R S, Burke J P.
Computerized
surveillance of adverse drug events in hospital
patients.
JAMA.
1991;
266
2847-2851
- 7
Classen D C, Pestotnik S L, Evans R S, Lloyd J F, Burke J P.
Adverse
drug events in hospitalized patients. Excess length of stay, extra costs, and
attributable
mortality.
JAMA.
1997;
277
301-306
- 8
Dartnell J G, Anderson R P, Chohan V, Galbraith K J, Lyon M E, Nestor P J, Moulds R F.
Hospitalisation
for adverse events related to drug therapy: Incidence, avoidability and
costs.
Med J
Aust.
1996;
164
659-662
- 9 Dormann H, Krebs S, Muth-Selbach U, Criegee-Rieck M, Radespiel-Tröger M, Levy M,
Hahn E G, Brune K, Schneider H T. Advancing
age and the risk for adverse drug reactions in gastroenterological
patients. (submitted) 2000
- 10
Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider H T, Hahn E G,
Levy M, Brune K, Geisslinger G.
Incidence
and costs of adverse drug reactions during hospitalisation: computerised
monitoring versus stimulated spontaneous reporting.
Drug
Saf.
2000;
22
161-168
- 11
Fletcher A P.
Spontaneous
adverse drug reaction reporting vs event monitoring: A comparison.
J R
Soc
Med.
1991;
84
341-344
- 12
Hoigne R, Lawson D H, Weber E.
Risk
factors for adverse drug reactions - epidemiological
approaches.
Eur J Clin
Pharmacol.
1990;
39
321-325
- 13
Hutchinson T A, Flegel K M, Kramer M S, Leduc D G, Kong H H.
Frequency,
severity and risk factors for adverse drug reactions in adult out-patients: A
prospective study.
J Chronic
Dis.
1986;
39
533-542
- 14
Jha A K, Kuperman G J, Teich J M, Leape L, Shea B, Rittenberg E, Burdick E, Seger D L,
Vander-Vliet M, Bates D W.
Identifying
adverse drug events: development of a computer-based monitor and comparison
with chart review and stimulated voluntary report.
J Am Med Inform
Assoc.
1998;
5
305-314
- 15
Lee A, Bateman D N, Edwards C, Smith J M, Rawlins M D.
Reporting
of adverse drug reactions by hospital pharmacists: pilot
scheme.
BMJ.
1997;
315
519
- 16
Levy M, Azaz-Livshits T, Sadan B, Shalit M, Geisslinger G, Brune K.
Computerized
surveillance of adverse drug reactions in hospital:
Implementation.
Eur J Clin
Pharmacol.
1999;
54
887-892
- 17
Levy M, Kewitz H, Altwein W, Hillebrand J, Eliakim M.
Hospital
admissions due to adverse drug reactions: a comparative study from Jerusalem
and Berlin.
Eur J Clin
Pharmacol.
1980;
17
25-31
- 18
Moride Y, Haramburu F, Requejo A A, Begaud B.
Under-reporting
of adverse drug reactions in general practice.
Br J Clin
Pharmacol.
1997;
43
177-181
- 19
Naranjo C A, Busto U, Sellers E M, Sandor P, Ruiz I, Roberts E A, Janecek E, Domecq C,
Greenblatt D J.
A
method for estimating the probability of adverse drug reactions.
Clin
Pharmacol
Ther.
1981;
30
239-245
- 20
Rieder M J.
Mechanisms
of unpredictable adverse drug reactions.
Drug
Saf.
1994;
11
196-212
- 21
Tegeder I, Levy M, Muth-Selbach U, Oelkers R, Neumann F, Dormann H, Azaz-Livshits T,
Criegee-Rieck M, Schneider H T, Hahn E, Brune K, Geisslinger G.
Retrospective
analysis of the frequency and recognition of adverse drug reactions by means of
automatically recorded laboratory signals.
Br J Clin
Pharmacol.
1999;
47
557-564
- 22
Voris J C, Dunphy M P.
A
postdischarge adverse drug reaction capture mechanism using medical record
technicians.
QRB Qual Rev
Bull.
1991;
17
293-296
- 23 et a l. WHO:
World Health Organization International drug monitoring. .The role
of the hospital. WHO Tech Rep Ser No.
425 1969
- 24
Winstanley P A, Irvin L E, Smith J C, Orme M L, Breckenridge A M.
Adverse
drug reactions: A hospital pharmacy-based reporting scheme.
Br J Clin
Pharmacol.
1989;
28
113-116
Korrespondenz
Dr. Sabine Krebs
Institut
für Experimentelle und Klinische Pharmakologie und
Toxikologie, Friedrich-Alexander Universität
Erlangen-Nürnberg
Fahrstraße 17
91054
Erlangen
